• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国 2 型糖尿病患者中非酒精性脂肪性肝病和肝硬化的患病率。

Prevalence of nonalcoholic fatty liver disease and liver cirrhosis in Chinese adults with type 2 diabetes mellitus.

机构信息

Department of Epidemiology, School of Public Health, Fudan University, Shanghai, China.

Key Laboratory of Public Health Safety (Fudan University), Ministry of Education, Shanghai, China.

出版信息

J Diabetes. 2024 May;16(5):e13564. doi: 10.1111/1753-0407.13564.

DOI:10.1111/1753-0407.13564
PMID:38664879
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11045916/
Abstract

BACKGROUND

Nonalcoholic fatty liver disease (NAFLD) and liver cirrhosis are significant clinical concerns, especially among individuals with type 2 diabetes mellitus (T2DM). However, in China, there is a paucity of reliable evidence detailing the characteristics of NAFLD and liver cirrhosis in T2DM. Furthermore, the relationship between blood glucose levels and NAFLD prevalence remains unclear.

METHODS

Data from the Shanghai Suburban Adult Cohort and Biobank were analyzed, including 6621 participants with T2DM. NAFLD was diagnosed by ultrasonography and liver cirrhosis was performed according to the health information systems. Logistic regression and restricted cubic spline analysis were used to explore the potential risk factors for NAFLD and liver cirrhosis.

RESULTS

The prevalence of NAFLD was 59.36%, and liver cirrhosis was 1.43% among T2DM patients. In these patients, factors like age, being female, marital status, and obesity significantly increased the risk of NAFLD. Specifically, obesity had a strong positive association with NAFLD (odds ratio [OR] = 4.70, 95% confidence interval [CI]: 4.13-5.34). The higher glycated hemoglobin (HbA1c) quartile was associated with a heightened NAFLD risk compared to the lowest quartile (all p < .001). The HbA1c-NAFLD relationship displayed a linear that mimicked an inverted L-shaped pattern. A significant positive association existed between HbA1c levels and NAFLD for HbA1c <8.00% (OR = 1.59, 95% CI: 1.44-1.75), but this was not observed for HbA1c >8.00% (OR = 1.03, 95% CI: 0.92-1.15).

CONCLUSION

Systematic screening for NAFLD is essential in T2DM patients, especially with poor glucose control and obesity in female.

摘要

背景

非酒精性脂肪性肝病(NAFLD)和肝硬化是重大临床关注点,尤其在 2 型糖尿病(T2DM)患者中更是如此。然而,中国缺乏详细描述 T2DM 患者中 NAFLD 和肝硬化特征的可靠证据。此外,血糖水平与 NAFLD 患病率之间的关系尚不清楚。

方法

对上海郊区成人队列和生物库中的数据进行了分析,纳入了 6621 例 T2DM 患者。NAFLD 通过超声诊断,肝硬化则根据健康信息系统进行诊断。采用 logistic 回归和限制立方样条分析来探讨 NAFLD 和肝硬化的潜在危险因素。

结果

T2DM 患者中,NAFLD 的患病率为 59.36%,肝硬化的患病率为 1.43%。在这些患者中,年龄、女性、婚姻状况和肥胖等因素显著增加了 NAFLD 的风险。具体而言,肥胖与 NAFLD 呈强正相关(比值比[OR] = 4.70,95%置信区间[CI]:4.13-5.34)。与最低四分位数相比,糖化血红蛋白(HbA1c)较高四分位数与更高的 NAFLD 风险相关(均 < .001)。HbA1c 与 NAFLD 之间的关系呈线性,类似于倒 L 形模式。在 HbA1c<8.00%时,HbA1c 水平与 NAFLD 之间存在显著的正相关(OR = 1.59,95%CI:1.44-1.75),但在 HbA1c>8.00%时则无此关联(OR = 1.03,95%CI:0.92-1.15)。

结论

在 T2DM 患者中,尤其是血糖控制不佳和肥胖的女性,系统筛查 NAFLD 至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40fe/11045916/2cd047b43566/JDB-16-e13564-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40fe/11045916/7c870664a0d9/JDB-16-e13564-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40fe/11045916/f7a693b041d5/JDB-16-e13564-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40fe/11045916/2cd047b43566/JDB-16-e13564-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40fe/11045916/7c870664a0d9/JDB-16-e13564-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40fe/11045916/f7a693b041d5/JDB-16-e13564-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40fe/11045916/2cd047b43566/JDB-16-e13564-g004.jpg

相似文献

1
Prevalence of nonalcoholic fatty liver disease and liver cirrhosis in Chinese adults with type 2 diabetes mellitus.中国 2 型糖尿病患者中非酒精性脂肪性肝病和肝硬化的患病率。
J Diabetes. 2024 May;16(5):e13564. doi: 10.1111/1753-0407.13564.
2
Study on the correlation between triglyceride glucose index, triglyceride glucose index to high-density lipoprotein cholesterol ratio, and the risk of diabetes in nonalcoholic fatty liver disease.非酒精性脂肪性肝病中甘油三酯葡萄糖指数、甘油三酯葡萄糖指数与高密度脂蛋白胆固醇比值与糖尿病风险的相关性研究
Front Endocrinol (Lausanne). 2025 Jun 23;16:1594548. doi: 10.3389/fendo.2025.1594548. eCollection 2025.
3
Control of cardiometabolic risk factors and their association with carotid intima media thickness among patients with type 2 diabetes mellitus-single center experience in a developing country.控制 2 型糖尿病患者的心血代谢风险因素及其与颈动脉内膜中层厚度的关系-发展中国家单中心的经验。
Turk J Med Sci. 2024 Jan 11;54(3):545-554. doi: 10.55730/1300-0144.5821. eCollection 2024.
4
Treatment of periodontal disease for glycaemic control in people with diabetes mellitus.糖尿病患者控制血糖的牙周疾病治疗
Cochrane Database Syst Rev. 2015 Nov 6;2015(11):CD004714. doi: 10.1002/14651858.CD004714.pub3.
5
The global impact of non-alcoholic fatty liver disease (including cirrhosis) in the elderly from 1990 to 2021 and future projections of disease burden.1990年至2021年非酒精性脂肪性肝病(包括肝硬化)对老年人的全球影响及疾病负担的未来预测。
PLoS One. 2025 Jun 25;20(6):e0325961. doi: 10.1371/journal.pone.0325961. eCollection 2025.
6
In Search of the Ideal Resistance Training Program to Improve Glycemic Control and its Indication for Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.寻找改善 2 型糖尿病患者血糖控制的理想抗阻训练方案及其适应证:系统评价和荟萃分析。
Sports Med. 2016 Jan;46(1):67-77. doi: 10.1007/s40279-015-0379-7.
7
[Association between obesity and the risk of microvascular complications in Yinzhou District, Ningbo adults with type 2 diabetes mellitus].[宁波鄞州区2型糖尿病成年患者肥胖与微血管并发症风险的相关性]
Wei Sheng Yan Jiu. 2025 Jul;54(4):608-620. doi: 10.19813/j.cnki.weishengyanjiu.2025.04.012.
8
Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus.二肽基肽酶(DPP)-4抑制剂和胰高血糖素样肽(GLP)-1类似物用于预防或延缓2型糖尿病高危人群发生2型糖尿病及其相关并发症。
Cochrane Database Syst Rev. 2017 May 10;5(5):CD012204. doi: 10.1002/14651858.CD012204.pub2.
9
Heterogeneity of cardiometabolic and hepatic fibrosis risks in nonalcoholic fatty liver disease among lean, overweight, and obese populations: a multicenter cross-sectional study.非酒精性脂肪性肝病中,瘦、超重和肥胖人群中心血管代谢及肝纤维化风险的异质性:一项多中心横断面研究。
Eur J Gastroenterol Hepatol. 2025 Aug 1;37(8):975-981. doi: 10.1097/MEG.0000000000002977. Epub 2025 Jun 18.
10
The association between resting heart rate and HbA1c-assessed glycemic control in patients with type 2 diabetes in Eastern China.中国东部2型糖尿病患者静息心率与糖化血红蛋白评估的血糖控制之间的关联。
Front Endocrinol (Lausanne). 2025 Jun 16;16:1478575. doi: 10.3389/fendo.2025.1478575. eCollection 2025.

引用本文的文献

1
Ethanol extract of seeds alleviates HGHFD/STZ-induced nonalcoholic fatty liver disease in diabetic rats by modulating oxidative stress, inflammation, and lipid accumulation.种子的乙醇提取物通过调节氧化应激、炎症和脂质积累,减轻了高糖高脂饲料/链脲佐菌素诱导的糖尿病大鼠非酒精性脂肪性肝病。
Iran J Basic Med Sci. 2025;28(5):662-670. doi: 10.22038/ijbms.2025.82786.17889.
2
Prevalence and Risk Factors of Non-Alcoholic Fatty Liver Disease in Central Region of Saudi Arabia: A Cross-Sectional Study.沙特阿拉伯中部地区非酒精性脂肪性肝病的患病率及危险因素:一项横断面研究
J Pharm Bioallied Sci. 2025 May;17(Suppl 1):S332-S335. doi: 10.4103/jpbs.jpbs_536_25. Epub 2025 Apr 29.
3

本文引用的文献

1
Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis.全球 2 型糖尿病中非酒精性脂肪性肝病的患病率:一项更新的系统评价和荟萃分析。
Gut. 2023 Nov;72(11):2138-2148. doi: 10.1136/gutjnl-2023-330110. Epub 2023 Jul 25.
2
Continuous Glucose Monitoring System Profile of Women Stratified Using Different Levels of Glycated Hemoglobin (HbA1c) in Early Pregnancy: A Cross-sectional Study.早孕期糖化血红蛋白(HbA1c)水平分层的女性连续血糖监测系统特征:一项横断面研究。
Adv Ther. 2023 Mar;40(3):951-960. doi: 10.1007/s12325-022-02405-w. Epub 2022 Dec 22.
3
MASLD: Prevalence, Mechanisms, and Sex-Based Therapies in Postmenopausal Women.
绝经后女性的代谢功能障碍相关脂肪性肝病:患病率、发病机制及基于性别的治疗方法
Biomedicines. 2025 Apr 2;13(4):855. doi: 10.3390/biomedicines13040855.
4
Prevalence and characteristics of liver steatosis and fibrosis in type 2 diabetes mellitus (T2DM) patients: a cross-sectional study in populations of eastern China.2型糖尿病(T2DM)患者肝脂肪变性和肝纤维化的患病率及特征:中国东部人群的横断面研究
BMJ Open. 2024 Dec 12;14(12):e087550. doi: 10.1136/bmjopen-2024-087550.
5
Bibliometric analysis of autophagy in NAFLD from 2004 to 2023.2004年至2023年非酒精性脂肪性肝病自噬的文献计量分析
Medicine (Baltimore). 2024 Dec 6;103(49):e40835. doi: 10.1097/MD.0000000000040835.
4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2023.
4. 全面的医学评估和共病评估:2023 年糖尿病护理标准。
Diabetes Care. 2023 Jan 1;46(Suppl 1):S49-S67. doi: 10.2337/dc23-S004.
4
Sex-specific differences in prevalence of nonalcoholic fatty liver disease in subjects with prediabetes and type 2 diabetes.性别特异性在糖尿病前期和 2 型糖尿病患者中非酒精性脂肪性肝病患病率的差异。
Diabetes Res Clin Pract. 2022 Aug;190:110027. doi: 10.1016/j.diabres.2022.110027. Epub 2022 Jul 30.
5
Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer.2010 年至 2019 年全球肝癌流行病学变化:NASH 是肝癌增长最快的病因。
Cell Metab. 2022 Jul 5;34(7):969-977.e2. doi: 10.1016/j.cmet.2022.05.003. Epub 2022 Jun 3.
6
Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病成人患者结局的前瞻性研究。
N Engl J Med. 2021 Oct 21;385(17):1559-1569. doi: 10.1056/NEJMoa2029349.
7
The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments.非酒精性脂肪性肝病与 2 型糖尿病之间的复杂关系——机制与治疗。
Nat Rev Gastroenterol Hepatol. 2021 Sep;18(9):599-612. doi: 10.1038/s41575-021-00448-y. Epub 2021 May 10.
8
Cancer Risk in Patients With Biopsy-Confirmed Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study.经活检证实的非酒精性脂肪性肝病患者的癌症风险:一项基于人群的队列研究。
Hepatology. 2021 Nov;74(5):2410-2423. doi: 10.1002/hep.31845. Epub 2021 Aug 25.
9
Glycemic Control Predicts Severity of Hepatocyte Ballooning and Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease.血糖控制可预测非酒精性脂肪性肝病中肝细胞气球样变和肝纤维化的严重程度。
Hepatology. 2021 Sep;74(3):1220-1233. doi: 10.1002/hep.31806. Epub 2021 Jun 2.
10
Gender-specific association between non-alcoholic fatty liver disease and type 2 diabetes mellitus among a middle-aged and elderly Chinese population: An observational study.非酒精性脂肪性肝病与中老年人群 2 型糖尿病的性别相关性:一项观察性研究。
Medicine (Baltimore). 2021 Feb 12;100(6):e24743. doi: 10.1097/MD.0000000000024743.